Chronic Disease and Vaccination

Chronic disease and vaccination concerns immunization in people with conditions such as diabetes, cardiovascular, chronic lung, kidney, or liver disease. The underlying illness raises both the likelihood and the severity of vaccine-preventable infection -- and can also trigger acute complications of the chronic condition itself -- which is why people with chronic disease are commonly prioritised for vaccines such as influenza and pneumococcal.

Definition

Chronic disease and vaccination refers to immunization considerations in people with long-term medical conditions in whom the underlying disease raises the risk and severity of vaccine-preventable infection and may precipitate acute decompensation, supporting prioritisation for vaccines such as influenza and pneumococcal.

Scope

The topic covers why chronic disease increases the consequences of vaccine-preventable infection, the distinction between chronic disease and frank immunosuppression, and the rationale for prioritising influenza and pneumococcal vaccination in these groups. It is reference material on the principles and supporting evidence, not individualized vaccination advice, and links to the immunocompromised-host topic where chronic disease overlaps with immune suppression.

Core questions

• Why does chronic disease increase the risk and severity of vaccine-preventable infection?
• How can infection precipitate acute complications of an underlying chronic condition?
• How does chronic disease differ from frank immunosuppression for vaccination purposes?
• Why are people with chronic disease prioritised for influenza and pneumococcal vaccination?

Key concepts

• Elevated infection severity in chronic disease
• Infection as a trigger of acute decompensation
• Influenza and cardiovascular events
• Pneumococcal disease risk with comorbidity
• Priority groups for influenza and pneumococcal vaccination
• Overlap with, and distinction from, immunosuppression
• Reduced physiologic reserve and infection outcomes

Mechanisms

Chronic disease worsens infection outcomes through two linked pathways. First, reduced physiologic reserve -- impaired cardiac, pulmonary, renal, or metabolic function -- means a vaccine-preventable infection is more likely to cause severe disease or death than in a healthy person; comorbidity is a recognised driver of severe pneumococcal disease, which conjugate vaccination can reduce (bonten-2015). Second, acute infection can directly destabilise the chronic condition: influenza, for example, is associated with a markedly increased short-term risk of acute myocardial infarction in the days after infection, an effect demonstrated in a self-controlled study and supported by meta-analysis (kwong-2018; barnes-2015). Unlike frank immunosuppression, many chronic diseases do not by themselves contraindicate live vaccines, though overlap with immunosuppressive therapy must be considered (rubin-2014).

Clinical relevance

People with chronic disease are widely recognised as priority groups for several routine vaccines because infection in them carries higher stakes. This entry explains the reasoning behind that prioritisation and the supporting evidence; it is reference material and does not provide individualized vaccination recommendations, which depend on the specific condition and any concurrent immunosuppressive therapy.

Epidemiology

Chronic non-communicable diseases are highly prevalent and account for a large share of severe outcomes from vaccine-preventable infections. Influenza is linked to acute cardiovascular events, and pneumococcal disease is more frequent and severe in people with comorbidity, which together place this population among the principal beneficiaries of immunization programmes (kwong-2018; bonten-2015).

Evidence & guidelines

Evidence relevant to this group spans trial and observational designs. A pneumococcal conjugate vaccine trial in adults supports protection against pneumococcal pneumonia, a major risk in those with comorbidity (bonten-2015); a self-controlled observational study and a meta-analysis link influenza to acute myocardial infarction, motivating influenza vaccination in cardiovascular disease (kwong-2018; barnes-2015). Where chronic disease overlaps with immunosuppression, the IDSA guideline for the immunocompromised host applies (rubin-2014), and standard vaccinology references synthesise immunization in chronic illness (plotkin-2018).

History

The recognition that chronic disease amplifies the harm of infection led to the long-standing practice of prioritising people with comorbidities for influenza and pneumococcal vaccination. More recent work clarifying the link between acute infection and cardiovascular events, alongside conjugate pneumococcal vaccine trials in adults, has sharpened the evidence behind this prioritisation (kwong-2018; bonten-2015).

Debates

Does vaccination reduce infection-triggered cardiovascular events?

Given the association between influenza and acute myocardial infarction, the extent to which influenza vaccination prevents such cardiovascular events in people with chronic disease is an actively studied question that strengthens the case for vaccination in this group.

Key figures

• Marc Bonten
• Jeffrey Kwong
• Lorry Rubin

Seminal works

• bonten-2015
• kwong-2018

Frequently asked questions

Why are people with chronic disease prioritised for vaccines like influenza and pneumococcal?

Chronic disease reduces physiologic reserve, so vaccine-preventable infections are more likely to cause severe illness, and infection can also precipitate acute complications of the underlying condition -- making prevention through vaccination especially valuable in this group.

Is having a chronic disease the same as being immunocompromised?

Not necessarily. Many chronic diseases raise infection risk through reduced reserve rather than direct immune suppression, so they differ from frank immunocompromise; the distinction matters, and overlap occurs when chronic disease is treated with immunosuppressive therapy.